SCHEMBL2279697

SCHEMBL2279697

CC(C(=O)O)c1nc2cnc3c(ccn3S(=O)(=O)c3ccccc3)c2n1C1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 9/20 0.40
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
CYP2D6 P10635 4/20 0.38
CYP2C9 P11712 4/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
JAK3 P52333 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277327 0.94 SMN1; SMN2 (0.40) GRIN2BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL2225399 0.84 LMNA (0.41) GRIN2BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL2276584 0.82 HTR6 (0.47) CYP3A4
SCHEMBL2224575 0.81 HTR6 (0.46) CYP3A4JAK2JAK1TYK2JAK3
SCHEMBL2280024 0.80 JAK1 (0.46) SMN1; SMN2CYP3A4JAK2JAK1TYK2
SCHEMBL2276095 0.79 JAK1 (0.42) SMN1; SMN2JAK2JAK1KMT2A
SCHEMBL13823531 0.79 JAK1 (0.43) CYP3A4JAK2JAK1TYK2JAK3
SCHEMBL25240038 0.77 HTR6 (0.43) JAK2JAK1
SCHEMBL2272937 0.77 HTR6 (0.43) JAK2JAK1
SCHEMBL25284995 0.77 HTR6 (0.43) JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed